Medicine for treating hyperplasia of mammary glands, mastodynia and general mammary diseases and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for mammary gland hyperplasia and mammary gland diseases, which can be applied in the direction of diseases, drug combinations, and pharmaceutical formulas, and can solve the problems of high price and limited wide application
Active Publication Date: 2012-01-11
THE FIRST HOSPITAL OF LANZHOU UNIV
View PDF1 Cites 11 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] It is particularly important to develop a Chinese patent medicine for the treatment of hyperplasia of mammary glands, mastalgia and general breast diseases. In 2008, we invented a drug for the treatment of hyperplasia of mammary glands, which has a good effect on treating hyperplasia of mammary glands and mastalgia. Good prospects for development, but there is a blind drug pangolin in its prescription, which is a national key protected species, and its use is prohibited in non-designated hospitals. At the same time, the price of pangolin is relatively expensive, which limits the wide application of the previous invention
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0138] 15 grams of Angelica, 9 grams of Yuanhu, 15 grams of Fritillaria, 12 grams of Wangbuliuxing, 12 grams of Rhizoma Cyperi, 12 grams of Curcuma, 9 grams of Bupleurum, 10 grams of Turtle Shell, 12 grams of Atractylodes macrocephala, 9 grams of Woody , Poria cocos 9 grams, saponins 6 grams, motherwort 15 grams.
Embodiment 2
[0140] 15 grams of Angelica, 12 grams of Yuanhu, 9 grams of Fritillaria, 9 grams of Wangbuliuxing, 15 grams of Cyperus Cyperi, 9 grams of Curcuma, 15 grams of Bupleurum, 15 grams of Turtle Shell, 9 grams of Atractylodes macrocephala, 12 grams of Woody Fragrance , Poria cocos 12 grams, saponins 9 grams, motherwort 9 grams, cistanche 15 grams.
Embodiment 3
[0142] 10 grams of Angelica, 12 grams of Yuanhu, 15 grams of Fritillaria, 15 grams of Wangbuliuxing, 9 grams of Rhizoma Cyperi, 15 grams of Curcuma, 9 grams of Bupleurum, 10 grams of Turtle Shell, 15 grams of Atractylodes macrocephala, and 15 grams of woody fragrance , 15 grams of Poria cocos, 6 grams of saponins, 12 grams of motherwort, 9 grams of cistanche, 9 grams of antler cream, and 9 grams of epimedium.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides a medicine for treating hyperplasia of mammary glands, mastodynia and general mammary diseases and a preparation method thereof, relating to the field of traditional Chinese medicine. At present, hormone replacement therapy is commonly used in western medicine, but the side effects are large, and the curative effects are dubious, however, traditional Chinese medicine has a good development prospect. The medicine comprises the following ingredients: 10-15 g of Chinese angelica, 9-15 g of rhizoma corydalis, 9-15 g of thunberg fritillary bulb, 9-15 g of cowherb seed, 9-15 g of Cyperus rotundus, 9-15 g of curcuma aromatica, 9-15 g of radix bupleuri, 10-15 g of turtle shell, 9-15 g of bighead atractylodes rhizome, 9-15 g of banksia rose, 9-15 g of Poria cocos, 6-9 g of gleditsia sinensis, and 9-15 g of motherwort. Experiments of pharmacodynamics,toxicology and clinical experiment prove that the medicine provided by the invention has the advantages of substantial curative effect, little toxic and side effect, convenient usage, low cost and the like.
Description
technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to medicines for treating breast diseases. Background technique [0002] Mammary gland hyperplasia is a common and frequently-occurring disease among women, accounting for the first place among breast diseases. According to domestic reports, the incidence rate is about 10%, and cystic hyperplasia and canceration can occur in 2-4% of them. In addition, this disease occurs in some men. also occurs; therefore, improving the curative effect of hyperplasia of mammary glands is crucial. [0003] At present, the Western medicine treatment of mammary gland hyperplasia mostly adopts hormone replacement therapy, but the side effects of hormone therapy are large, the curative effect is not exact, not consolidated, and endocrine disorders are prone to occur. Traditional Chinese medicine has a relatively unified understanding of the etiology and pathogenesis of hyperplasia of the ma...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.